Sulfotransferase sequence variants

Chemistry: molecular biology and microbiology – Vector – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023200, C536S024310, C435S193000

Reexamination Certificate

active

07026163

ABSTRACT:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to thyroid disease or cancer also are described.

REFERENCES:
patent: 5451683 (1995-09-01), Barrett et al.
patent: 5733729 (1998-03-01), Lipshutz et al.
patent: 5770722 (1998-06-01), Lockhart et al.
patent: 6265561 (2001-07-01), Weinshilboum et al.
patent: WO 98/20019 (1998-05-01), None
patent: WO 99/57318 (1999-11-01), None
patent: WO 99/64630 (1999-12-01), None
patent: WO 00/20605 (2000-04-01), None
Mehmann et al. (1994) Appl. Environ. Microbiol., vol. 60(9), pp. 3105-3111.
Mehmann (Sep. 23, 1994) GenBank accession X78089.
GenBank Accession No. U66036, (Her et al., May 12, 1997).
GenBank Accession No. AF186251, (Freimuth et al., May 31, 2000).
GenBank Accession No. AF186252, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186253, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186254, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186255, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186256, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186257, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186258, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186259, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186260, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186261, (Freimutle et al., May 31, 2000).
GenBank Accession No. AF186262, (Freimutle et al., May 31, 2000).
Campbell et al., “Human Liver Phenol Sulftransferase: Assay Conditions, Biochemical Properties and Partial Purification of Isozymes of the Thermostable Form,”Biochem. Pharmoacol., 1987, 36(9):1435-1446.
Cleland, “Computer Programmes for Processing Enzyme Kinetic Data,”Nature, 1963, 198:463-465.
Freimuth et al., “Pharmacogenetics of Human Sulfotransferase (Sult) IC1:Gene Cloning, Resequencing and Common Single Nucleotide Polymorphisms,”Clinical Pharmacology&Therapeutics. 2000, 67(2):140.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci. USA, 1983, 80:2026-2030.
Hacia et al., “Detection of heterozygous mutations inBRCA1using high density oligonuclcotide arrays and two-color fluorescence analysis,”Nat. Genet., 1996, 14:441-447.
Halushka et al., “Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis,”Nat. Genet., 1999. 22:239-247.
Her et al., “Human Sulfotransferase SULT1C1: cDNA Cloning, Tissue-Specific Expression. and Chromosomal Localization,”Genomics, 1997, 41:467-470.
Ho et al., “Site-directed mutagenesis by overlap extension using the polymerase chain reaction,”Gene. 1989, 77:51-59.
Huse et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,”Science, 1989, 246:1275-1281.
Hyrup and Nielsen, “Peptide Nucleid Acids (PNA): Synthesis, Properties and Potential Applications,”Bioorgan. Med. Chem., 1996, 4:5-23.
Myakishev et al., “High-Throughput SNP Genotyping by Allele-Specific PCR with Universal Energy-Transfer-Labeled Primers,”Genome Res., 2001, 11:163-169.
Prince et al., “Robust and Accurate Single Nucleotide Polymorphism Genotyping by Dynamic Allelc-Specific Hybridization (DASH): Design Criteria and Assay Validation,”Genome Res., 2001, 11:152-162.
Sakakibara et al., “Molecular Cloning, Expression, and Characterization of Novel Human SULT1C Sulfotransferases That Catalyze the Sulfonation of N-Hydroxy-2-acetylaminofluorene,”J. Biol. Chem., 1998, 273(51):33929-33935.
Schafer and Hawkins, “DNA variation and the future of human genetics.”Nat. Biotechnol., 1998, 16:33-39.
Stoneking et al., “Population Variation of Human mtDNA Control Region Sequences Detected by Enzymatic Amplification and Sequence-specific Oligonucleotide Probe,”Am. J. Hum. Genet., 1991, 48:370-382.
Summerton and Weller, “Morpholino Antisense Oligomers: Design, Preparation, and Properties.”Antisense&Nucleic Acid Drug Development, 1997, 7:187-195.
Terwilliger and Ott,Handbook of Human Genetic Linkage. The Johns Hopkins University Press, Baltimore and London, 1994, pp. 188-193.
Underhill et al., “Detection of Numurous Y Chromosome Biallelic Polymorphisms by Denaturing High-Performance Liquid Chromatography.”Genome Res.. 1997. 7 (10):996-1005.
Van Loon et al., “Human Kidney Thiopurine Methyltransferase Photoaffinity Labeling with S-Adenosyl-L-Methionine.”Biochem. Pharmacol.. 1992, 44(4):775-785.
Van Loon and Weinshilboum, “Thiopurine Methyltransferase Isozymes in Human Renal Tissue,”Drug Metab. Dispos., 1990, 18(5):632-638.
Wilkinson, “Statistical Estimations in Enzyme Kinetics,”Biochem, J., 1961. 80:324-332.
Wong et al., “Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins,”Science, 1985, 228:810-815.
Wood et al., “Human Liver Thermolabile Phenol Sulfotransferase: cDNA Cloning, Expression and Characterization,”Biochem. Biophys. Res. Commun., 1994, 198(3):1119-1127.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfotransferase sequence variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfotransferase sequence variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfotransferase sequence variants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3597100

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.